In our study, we noticed an interesting trend concerning CCL22/MDC in COVID-19 pathogenesis: namely, a decrease in the concentrations of this chemokine in comparison with healthy donors.
← all excerpts
A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants.
1
—
—